Accueil > History

History

In 2003, Pr J.M. François and Pr J.P. Majoral patented the dendrimer-based DNA microarrays technology for molecular diagnosis. This technology is based on the coating of phosphorus dendrimers on solid supports. This allows covalent linkages of oligonucleotide probes, which greatly optimizes DNA hybridization (i.e.10-fold higher signal than other commercial technologies). From 2003 to 2007, the proof of concept and technological readiness has been demonstrated in several publications.
In 2009, Dr R. Fabre, biologist (Bio Pôle), founding biologist of the Biopole laboratory discovers J.M. François and J.P. Majoral ’s invention. Together they decide to create a company with the aim of developing a new generation of diagnostic tools exploiting the invention of the two researchers.

The Dendris company was therefore born from the cooperation of scientists and a practicing biologist and is based on the exploitation of this surface chemistry by Dendrimers.
M. Corbarieu and A. Leonard, successful entrepreneurs joined Dendris in 2010, as business manager and member of the guidance and supervision service respectively.

Frenchtech

LBM Biopole partnership

BSI
CE mark
Partnership
BSI
Clinical validation
Development

Development
Validation of an
automated version

Contract of
Co-development

CE Mark
– DKIT OA
– DKIT DP
CE + IVD

CE mark
Launch

The new generation of Dendris solutions allows laboratories to use a powerful and intelligent syndromic approach to strengthen collaboration with clinicians and protect patients at risk